Unreconstituted lyophilised KLOW peptides stored at 20C retain 95%+ potency for 1218 months
The safety profile of AXA1125, combined with its potential to improve mitochondrial function and reduce oxidative damage, warrants further investigation in clinical trials in ME/CFS and GWS patients
Studies have found 12 to 58 percent of supplements in this space are contaminated, with 30 percent containing incorrect sequences and 65 percent exceeding safe endotoxin levels
Li W, Wang Q, Du M, Ma X, Wu L, Guo F, Zhao S, Huang F, Wang H, Qin G
even using the same region back-to-back may cause issues
Among them, oltipraz is the most extensively studied